Laboratory Products 27 Powder Dosing Technology Recognised with the Queen’s Award 2020 for Enterprise in Innovation
3P is delighted to have been awarded with the Queen’s Award for Enterprise in Innovation, in recognition of their Fill2Weight powder micro-dosing technology. Fill2Weight was developed 12 years ago after 3P engineers identifi ed challenges in the fi eld of micro-dosing and fi lling of powders for inhalers, that could be overcome with the application of technologies in a new and novel way. The Queen’s Awards have recognised the technology as a great example of innovation, where several different technologies have been combined into one highly effective and versatile solution.
Now used for multiple pharmaceutical applications, Fill2Weight precisely fi lls a wide range of pharmaceutical containers, including capsules, vials, inhalers, syringes, cartridges, blisters and other special containers.
A major challenge Fill2Weight addresses is getting challenging powders to fl ow so that very small (down to 1mg) and precise doses can be created. This is essential for high-potency drugs, where inaccurate dosing poses risks to patient safety. Its gravimetric system weighs and verifi es every dose. Any doses outside the limits are rejected.
As well as excelling in accuracy, Fill2Weight is the fastest gravimetric dosing system on the market. Fill2Weight’s ability to handle challenging powders helps reduce drug development lead-times by enabling pharma companies to avoid or reduce the need for costly and time consuming ‘formulation for fi lling’ development work. This means customers can achieve ‘fi rst-in-human’ milestones faster, with potential for new drug launch in shorter time-frames.
Fill2Weight is a fl exible and scalable system, ensuring early-stage manufacturing processes can also be used for commercial production. Its narrow design allows for multiple modules to be installed side-by- side, creating a multi-lane solution for higher volume production.
Another challenge 3P addressed was to ensure the technology could accommodate changing powder properties throughout a batch. Conventional fi lling systems cannot do this, affecting accuracy. Fill2Weight’s intelligent software algorithms automatically detect changing properties and modify dose settings to suit.
Fill2Weight’s technology requires as little as 2-3 grams for doses to be created for administration to patients or for other development tests, minimising the amount of drug product required. Unused powder can be recovered, meaning zero waste.
More information online:
ilmt.co/PL/0gM0
British Manufacturer Gains Saudi Arabian FDA Approval for its Autoclave range
52278pr@reply-direct.com New Environmental Swabbing Method for COVID-19 Detection Introduced
Socotec, a leading UK provider of testing, inspection and compliance services, has introduced a new environmental swabbing procedure to determine the presence of SARS-CoV-2 (Coronavirus) on surfaces across a range of workplace environments.
The new method has been adopted in light of preliminary research which indicates that the COVID-19 virus has prolonged tenacity on surfaces, with contact via contaminated surfaces suggested as a possible cause of infection.
This swabbing procedure can be applied across a variety of workplace environments, including offi ces, factories, communal/public areas and public transportation, testing such surfaces as door/grab handles, light switches, HVAC vents, table/desk tops, offi ce equipment, control panels, seat backs, sinks and toilet cubicles amongst others.
To carry out the test, sterile swabs will be gently rubbed and rolled over a set area of the surface to be sampled. This process is repeated using fresh swabs for all other areas and locations that require sampling. Analysis is carried out by a specialist partner laboratory using Ribonucleic acid (RNA) testing, which detects the presence of SARS-CoV-2 viral RNA fragments.
Results will be reported in a comprehensive format comprising observations, salient points and recommendations for improvement, ensuring full compliance with relevant legislation. Photographic evidence will also be compiled within the report to indicate precisely where samples were taken.
As a leading British autoclave manufacturer, Priorclave is delighted to announce that it has gained approval by the SFDA- Saudi Food & Drug Authority for its entire range of range of research grade laboratory autoclaves. This is an important development and will enable the company to further expand its business in the region.
Priorclave has developed and manufactures more than 60 standard laboratory models at its UK production facility. The range includes benchtop, front and top loading sterilisers, pass-through and stackable models. Every single unit is ETL- listed and EMC-certifi ed, entirely manufactured in it UKAS-accredited manufacturing facility, with CE-Marked, PED-certifi ed pressure vessels. And units bound for the North American market feature ASME-stamped pressure vessels.
Priorclave produces laboratory autoclaves that have become renowned for reliability, durability, repeatable performance all backed by a superb aftersales support team. These credentials have enabled the company to gain a global presence, supplying steam sterilisers to virtually every country in the world.
The SFDA has classifi ed Priorclave Autoclaves suitable for General Lab Use following rigorous appraisals of certifi ed documentation. This ensures this established manufacturer of research grade laboratory autoclaves is authorised to supply equipment knowing that it complies with requirements set down by the SFDA
This will further strengthen opportunities for Priorclave to grow and develop increased sales into a region where it has already gain signifi cant contracts over many years.
More information online:
ilmt.co/PL/zVez 52375pr@reply-direct.com
“As certain Government restrictions surrounding the COVID-19 pandemic begin to ease, many organisations are now facing the overwhelming task of returning their buildings to full occupancy. Socotec is committed to guiding and supporting its clients as they prepare to resume business operations, ensuring that they remain safe and compliant while doing so,” said Norman Sleeth, Managing Director, Environment & Safety, Socotec UK.
“Our new environmental swabbing method forms just one of Socotec’s wide range of testing, inspection and compliance services that aims to get buildings ‘business ready’, instilling employers with confi dence and reassurance regarding occupational health, safety and hygiene as they continue to operate through these uncertain times.”
More information online:
ilmt.co/PL/Q0VR 52305pr@reply-direct.com
COVID-19 ELISA Antibody Tests are now available for high capacity automation
Aspect Scientific specialise in ELISA automation systems and offer a range of instrumentation from Dynex Technologies capable of automating any level of workload quickly and easily.
The Dynex Agility is a highly advanced market leading ELISA processor, with huge capability, handling up to 12 96-well microplates simultaneously. The Agility provides true high capacity and high throughput, with continuous sample loading for high demands. State-of-the-art robotic processing delivers unparalleled precision while eliminating nearly all manual steps, the system is streamlined for maximum efficiency, speed and productivity, yet also providing operating cost and time savings.
In addition to the Agility, the 2-plate Dynex DS2 and 4-plate DSX are extremely widely used, flexible and open systems designed to provide walk away automation with incredible ease of use.
Aspect Scientific are able to integrate these systems into your lab, quickly, anywhere in the UK, backed up with our comprehensive technical service and support through every stage of implementation and thereafter
Take advantage of the availability, reliability and cost effectiveness of ELISA assays combined with high capacity automation.
Contact us for further information.
www.aspectscientific.com | 01829 824 825
COVID-19_PATHINPRACTICEHALFPAGE.indd 1 14/05/2020 12:51
WWW.LABMATE-ONLINE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40